1998
DOI: 10.1159/000017882
|View full text |Cite
|
Sign up to set email alerts
|

Eccrine Syringofibroadenoma: Report of a Case and Analysis of Cytokeratin Expression

Abstract: Eccrine syringofibroadenoma (ESFA) is a rare disorder which shows differentiation toward the eccrine sweat apparatus. There is a controversy concerning the pathogenesis and precise differentiation of this tumor. We report a case of ESFA and its differentiation pattern by an analysis of cytokeratin expression. Using paraffin-embedded materials, histopathological and immunohistochemical studies were performed. Staining patterns of the luminal, peripheral, and inner cells of the tumor strands closely matched or m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
14
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(15 citation statements)
references
References 21 publications
1
14
0
Order By: Relevance
“…In addition, the increased mast cells observed in several of these cases1011 are a characteristic feature of healing wounds and also suggest that ESFA may be a response of the eccrine duct to ongoing tissue remodeling. The histological presentation of ESFA is unique, and the ultrastructural and immunohistochemical features reported in the literature support acrosyringeal11 or intradermal eccrine duct differentiation1213. However, because of the clinical polymorphism, it is still unclear whether ESFA is a neoplasm, hamartoma, or reactive eccrine hyperplasia.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the increased mast cells observed in several of these cases1011 are a characteristic feature of healing wounds and also suggest that ESFA may be a response of the eccrine duct to ongoing tissue remodeling. The histological presentation of ESFA is unique, and the ultrastructural and immunohistochemical features reported in the literature support acrosyringeal11 or intradermal eccrine duct differentiation1213. However, because of the clinical polymorphism, it is still unclear whether ESFA is a neoplasm, hamartoma, or reactive eccrine hyperplasia.…”
Section: Discussionmentioning
confidence: 99%
“…* The consensus belief is that ESFA derives from or differentiates toward the acrosyringium or eccrine dermal duct. [8][9][10][11][12][13][14] It is still unclear whether the lesion is neoplastic, hamartomatous, or reactive in nature. 5,21,[24][25][26][27] ESFA typically presents in older adults with a predilection for the extremities.…”
Section: Discussionmentioning
confidence: 99%
“…22,28 Immunohistochemical studies show that the lesional cells are positive for keratin 6, keratin 19, and filaggrin. [9][10][11][12]14,23 In addition, electron microscopic studies show that the ducts have a keratinization pattern similar to acrosyringeal cells. 9,13 ESFA has been associated with numerous entities/conditions, which are summarized in Table I.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There is a controversy concerning the histogenesis and the precise differentiation of this tumor. Based on cytokeratin expression, some reports suggested acrosyringeal differentiation [3, 4], others suggested differentiation towards the eccrine dermal duct [5, 6, 7]and some results even suggested dual acrosyringeal and dermal duct differentiation [8]. ESFA is a characteristic histologic entity (reticulate proliferation of epithelial cells with eccrine duct lumina in fibrovascular stroma) with a polymorphous clinical presentation: either papules, nodules or plaques, solitary or multiple.…”
Section: Discussionmentioning
confidence: 99%